Pantoprazole-Induced Liver Injury in the Setting of Diabetic Ketoacidosis

Raquel Oliveira; Manuel Almeida; Pedro Lavado; Alexandre Baptista

doi:10.20344/amp.20928

Pantoprazole-Induced Liver Injury in the Setting of Diabetic Ketoacidosis

Authors

Raquel Oliveira Gastroenterology Department. Centro Hospitalar Universitário do Algarve. Portimão; Algarve Biomedical Centre (ABC). Universidade do Algarve. Faro.
Manuel Almeida Intensive Care Unit. Centro Hospitalar Universitário do Algarve. Portimão. https://orcid.org/0000-0001-9439-3105
Pedro Lavado Intensive Care Unit. Centro Hospitalar Universitário do Algarve. Portimão. https://orcid.org/0000-0002-6922-2774
Alexandre Baptista Gastroenterology Department. Centro Hospitalar Universitário do Algarve. Portimão; Intensive Care Unit. Centro Hospitalar Universitário do Algarve. Portimão. https://orcid.org/0000-0002-2746-5815

DOI:

https://doi.org/10.20344/amp.20928

Keywords:

Chemical and Drug Induced Liver Injury, Diabetic Ketoacidosis, Pantoprazole

Abstract

N/a.

Downloads

Download data is not yet available.

References

Lescot T, Karvellas C, Beaussier M, Magder S, Riou B. Acquired liver injury in the intensive care unit. Anesthesiol. 2012;117:898-904.

EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol. 2019;70:1222-61.

Aslan M, Celik Y, Karadas S, Olmez S, Cifci A. Liver hepatotoxicity associated with pantoprazole: a rare case report. Wien Klin Wochenschr. 2014;126:390-2.

Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci. 2016;17:14.

National Center for Biotechnology Information. Pantoprazole. 2012. [updated 2019 Apr 15]. In: LiverTox: clinical and research information on drug-induced liver injury. [cited 2023 November 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK548461/.

Downloads

Published

2024-04-01

How to Cite

Oliveira R, Almeida M, Lavado P, Baptista A. Pantoprazole-Induced Liver Injury in the Setting of Diabetic Ketoacidosis. Acta Med Port [Internet]. 2024 Apr. 1 [cited 2024 Nov. 24];37(4):308-9. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/20928

Download Citation

Issue

Vol. 37 No. 4 (2024): April

Section

Letters to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.